Key points are not available for this paper at this time.
Ligand-based nanotechnology is promising in enhancing targeted drug delivery in autoimmune disorders. This study explores molecular targets and new active targeting techniques. These technologies enhance drug specificity via precise targeting.
Karmarkar et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: